| Drugs | Target type | Relation | Relation effect | Target |
| 2-Methoxyestradiol | Protein | Expression | Positive | BAX, TP53 | Negative | HIF1A, IL6, PCNA, TNF, VEGFA | Regulation | Positive | CASP9, MAPK8 | Negative | BCL2, HIF1A, SOD2 | Cell process | Regulation | Positive | Apoptosis, autophagy, cell cycle arrest, cell death, DNA damage, mitochondrial damage, oxidative stress, ROS generation | Negative | Angiogenesis, cell cycle, cell growth, cell invasion, cell proliferation, cell survival, mitochondrial respiration, tumor growth | Disease | Regulation | Negative | Atherosclerosis, breast cancer, hepatocellular carcinoma, melanoma, pancreatic cancer |
| Buthionine sulfoximine | Protein | Expression | Positive | BCL2, HMOX1, JUN, NFE2L2, SOD2, TNF | Negative | GPX1, IL6, NOS2 | Regulation | Positive | BCL2, CASP3, MAPK14 | Negative | GCLC | Cell process | Regulation | Positive | Apoptosis, autophagy, cell death, cytotoxicity, DNA damage, lipid peroxidation, oxidative stress, ROS generation | Negative | Cell growth, cell proliferation, tumor growth | Disease | Regulation | Positive | Cataract, liver injury, necrosis, neurotoxicity, toxicity | Negative | Hepatocellular carcinoma, lung cancer |
| Cisplatin | Protein | Expression | Positive | ABCC1, BAX, BBC3, BECN1, CASP3, CASP8, CASP9, CYCS, DDIT3, FAS, FASLG, GPT, H2AFX, HMOX1, IL1B, IL6, JUN, NFE2L2, NOS2, TNF, TP53 | Negative | BCL2, SOD2, XIAP | Regulation | Positive | CASP3, CASP7, CYCS, G6PD, MAPK14, MAPK3, MAPK8, TP53 | Negative | SOD1 | Cell process | Regulation | Positive | Apoptosis, autophagy, cell cycle arrest, cell death, cytotoxicity, DNA damage, lipid peroxidation, mitochondrial damage, oxidative stress, ROS generation | Negative | Angiogenesis, cancer cell growth, cell growth, cell invasion, cell proliferation, cell survival, tumor growth | Disease | Regulation | Positive | Acute kidney injury, kidney disease, liver injury, necrosis, neurotoxicity, renal dysfunction, toxicity | Negative | Breast cancer, colorectal cancer, gastric cancer, hepatocellular carcinoma, lung cancer, lymphoma, melanoma, metastasis, ovarian cancer, pancreatic cancer |
| Doxorubicin | Protein | Expression | Positive | ABCC1, BAX, BBC3, BECN1, CASP3, CASP7, CASP8, CASP9, CAT, CYCS, DDIT3, FAS, FASLG, GPX1, H2AFX, HMOX1, IL1B, IL6, MAPK3, MAPK8, NFE2L2, NOS2, SOD1, TNF, TP53 | Negative | BCL2, PCNA, VEGFA, XIAP | Regulation | Positive | ANXA5, CASP3, CASP7, CASP8, FAS, GPT, IL6, MAPK14, MAPK3, MAPK8, NOS2, TP53 | Negative | HIF1A | Cell process | Regulation | Positive | Apoptosis, autophagy, cell cycle arrest, cell death, cytotoxicity, DNA damage, lipid peroxidation, mitochondrial damage, oxidative stress, ROS generation | Negative | Angiogenesis, cancer cell growth, cell growth, cell proliferation, cell survival, DNA repair, mitochondrial respiration, tumor growth | Disease | Regulation | Positive | Acute kidney injury, kidney disease, liver injury, necrosis, neurotoxicity, renal dysfunction, toxicity | Negative | Breast cancer, colorectal cancer, gastric cancer, hepatocellular carcinoma, lung cancer, lymphoma, melanoma, metastasis, ovarian cancer, pancreatic cancer |
| Imexon | Protein | Expression | Negative | HIF1A | Regulation | Positive | CASP3, CASP9 | Cell process | Regulation | Positive | Apoptosis, cell cycle arrest, oxidative stress | Negative | Cancer cell growth, cell cycle, cell growth, tumor growth | Disease | Regulation | Negative | Lymphoma, melanoma, multiple myeloma, splenomegaly |
| Motexafin gadolinium | Protein | Regulation | Negative | HMOX1, TXN | Cell process | Regulation | Positive | Apoptosis, cell death, cytotoxicity, oxidative stress, ROS generation | Negative | Cell proliferation, cell survival, DNA repair, tumor growth | Disease | Regulation | Negative | Atherosclerosis, cerebral neoplasm, glioblastoma, lung cancer, metastasis |
|
|